Total Payments
$677.08
2024 Payments
$250.64
Companies
12
Transactions
39
Medicare Patients
177
Medicare Billing
$87,710
Payment Breakdown by Category
Food & Beverage$677.08 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $677.08 | 39 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $111.73 | 6 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $103.22 | 6 | $0 (2024) |
| Corium, LLC | $80.07 | 5 | $0 (2024) |
| ABBVIE INC. | $79.47 | 5 | $0 (2024) |
| ITI, Inc. | $68.10 | 4 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $58.33 | 3 | $0 (2024) |
| Lundbeck LLC | $53.66 | 3 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $43.50 | 2 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $31.49 | 2 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $19.11 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $250.64 | 14 | Lundbeck LLC ($53.66) |
| 2023 | $178.40 | 10 | ABBVIE INC. ($44.98) |
| 2022 | $193.17 | 11 | Alkermes, Inc. ($51.91) |
| 2021 | $37.37 | 3 | Neurocrine Biosciences, Inc. ($13.99) |
| 2020 | $17.50 | 1 | Neurocrine Biosciences, Inc. ($17.50) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: PSYCHIATRY | ||||||
| 07/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: PSYCHIATRY | ||||||
| 06/27/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Neuroscience | ||||||
| 06/27/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.98 | General |
| Category: PSYCHIATRY | ||||||
| 06/19/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.33 | General |
| Category: PSYCHIATRY | ||||||
| 06/18/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Central Nervous System | ||||||
| 05/01/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.35 | General |
| Category: PSYCHIATRY | ||||||
| 03/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: PSYCHIATRY | ||||||
| 03/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: CNS | ||||||
| 01/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: PSYCHIATRY | ||||||
| 01/11/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 01/10/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: CNS | ||||||
| 11/30/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: CNS | ||||||
| 10/16/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: PSYCHIATRY | ||||||
| 08/22/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: Central Nervous System | ||||||
| 07/31/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: PSYCHIATRY | ||||||
| 07/20/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: NEUROSCIENCE | ||||||
| 03/02/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: PSYCHIATRY | ||||||
| 02/06/2023 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Neurology | ||||||
| 01/09/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: NEUROSCIENCE | ||||||
| 01/05/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 12/14/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 35 | 148 | $34,695 | $6,534 |
| 2022 | 2 | 42 | 136 | $27,980 | $7,501 |
| 2021 | 3 | 47 | 276 | $91,500 | $34,356 |
| 2020 | 3 | 53 | 328 | $111,035 | $39,319 |
Total Patients
177
Total Services
888
Medicare Billing
$87,710
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 93 | $22,320 | $3,328 | 14.9% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 16 | 55 | $12,375 | $3,206 | 25.9% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 21 | 68 | $14,020 | $4,161 | 29.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 68 | $13,960 | $3,340 | 23.9% |
| 90868 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression), subsequent delivery and management, per session | Office | 2021 | 12 | 165 | $70,125 | $28,270 | 40.3% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 17 | 55 | $10,175 | $3,393 | 33.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 18 | 56 | $11,200 | $2,693 | 24.0% |
| 90868 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression), per session | Office | 2020 | 17 | 206 | $87,550 | $32,845 | 37.5% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 18 | 61 | $11,285 | $3,984 | 35.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 18 | 61 | $12,200 | $2,490 | 20.4% |
About Dr. Leonard Marcus, MD
Dr. Leonard Marcus, MD is a Psychiatry healthcare provider based in Randolph, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1730165119.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leonard Marcus, MD has received a total of $677.08 in payments from pharmaceutical and medical device companies, with $250.64 received in 2024. These payments were reported across 39 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($677.08).
As a Medicare-enrolled provider, Marcus has provided services to 177 Medicare beneficiaries, totaling 888 services with total Medicare billing of $87,710. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Randolph, MA
- Active Since 12/19/2005
- Last Updated 09/17/2012
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1730165119
Products in Payments
- REXULTI (Drug) $156.88
- CAPLYTA (Drug) $111.60
- VRAYLAR (Drug) $79.47
- ARISTADA (Drug) $74.41
- AZSTARYS (Drug) $45.03
- Austedo XR (Drug) $39.42
- LYBALVI (Drug) $37.32
- Azstarys (Drug) $35.04
- INGREZZA (Drug) $31.49
- INVEGA SUSTENNA (Drug) $19.11
- AUSTEDO (Drug) $18.91
- APLENZIN (Drug) $16.39
- ADUHELM (Biological) $12.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Randolph
Fiona Mudge, Md, MD
Psychiatry — Payments: $10,188
Psychiatry $10,188
Gary Warstadt, Md, MD
Psychiatry — Payments: $9,315
Psychiatry $9,315
Edith Pepper
Psychiatry — Payments: $6,861
Psychiatry $6,861
Dean Solomon, Md, MD
Psychiatry — Payments: $5,893
Psychiatry $5,893
Dr. Krishnaswamy Gajaraj, M.d, M.D
Psychiatry — Payments: $1,881
Psychiatry $1,881
Dr. Michael Krysko, Md, MD
Psychiatry — Payments: $489.58
Psychiatry $489.58